NEW YORK (GenomeWeb) – Researchers from the Broad Institute and the Massachusetts Institute of Technology this week reported on a new technique that enables inducible gene editing and transcription modulation via CRISPR/Cas9.

CRISPR — short for clustered, regularly interspaced, short palindromic repeats — involves the use of a nuclease known as Cas9 to induce double-strand DNA breaks (DSBs). These breaks are targeted to specific locations in the genome using a synthetic RNA, known as a guide RNA, that directs Cas9.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.

Sep
21
Sponsored by
Roche

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Sep
26
Sponsored by
PerkinElmer

This webinar will describe a protocol and proof-of-principle experiments for Cellular Indexing of Transcriptome and Epitopes by Sequencing (CITE-seq).